Effect of naringin and cisplatin combination on cell viability and cell death in bladder cancer cells
Open Access
- 8 April 2025
- journal article
- Published by Marmara University in Journal of Research in Pharmacy
- Vol. 29 (2) , 673-681
Abstract
Bladder cancer is a prevalent malignancy characterized by high recurrence rates and limited therapeutic options, particularly due to resistance and toxicity associated with cisplatin therapy. Bladder cancer remains a significant global health concern, and while cisplatin is a cornerstone of treatment, its efficacy is often limited by resistance and toxicity. Therefore, there is a critical need for novel agents that can enhance cisplatin's effects while mitigating its drawbacks. This study investigates the potential of naringin, a natural flavonoid, to exhibit antiproliferative and proapoptotic effects in human bladder cancer cell lines (HTB-9 and HT-1376), both as a monotherapy and in combination with cisplatin. Cytotoxicity was assessed via the MTT ((3-(4,5-dimetiltiazol-2-il)-2,5 difeniltetrazoliumbromid) assay, and apoptosis was evaluated using Annexin V/PI staining and caspase 3/7 activation assays. Results demonstrated that naringin reduced cell viability in a dose-dependent manner in both cell lines. When combined with cisplatin, naringin significantly enhanced the antiproliferative and pro-apoptotic effects compared to either treatment alone. Caspase 3/7 activity was markedly elevated in the combination groups, indicating an amplified apoptotic response. These findings suggest that naringin can potentiate cisplatin’s efficacy and could serve as a promising adjunctive therapy in bladder cancer treatment. Further studies are warranted to explore the underlying mechanisms and potential clinical applications of naringin in enhancing cisplatin-based chemotherapy.Keywords
This publication has 25 references indexed in Scilit:
- Effect of Herniarin on Cell Viability, Cell Cycle, and Erk Protein Levels in Different Stages of Bladder Cancer CellsChemistry & Biodiversity, 2024
- Combined effects of naringin and doxorubicin on the JAK/STAT signaling pathway reduce the development and spread of breast cancer cellsScientific Reports, 2024
- Suppression of colorectal carcinogenesis by naringinPhytomedicine, 2022
- Comparison of Microscopic Hematuria Guidelines as Applied in 1018 Patients With Microscopic HematuriaUrology, 2021
- Naringin Combined with NF-κB Inhibition and Endoplasmic Reticulum Stress Induces Apoptotic Cell Death via Oxidative Stress and the PERK/eIF2α/ATF4/CHOP Axis in HT29 Colon Cancer CellsBiochemical Genetics, 2020
- Naringin inhibits thyroid cancer cell proliferation and induces cell apoptosis through repressing PI3K/AKT pathwayPathology - Research and Practice, 2019
- Dihydrotestosterone increases the risk of bladder cancer in menHuman Cell, 2019
- Pure total flavonoids from Citrus paradisi Macfad induce leukemia cell apoptosis in vitroChinese Journal of Integrative Medicine, 2016
- Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversityNature Reviews Cancer, 2014
- Naringin induces death receptor and mitochondria-mediated apoptosis in human cervical cancer (SiHa) cellsFood and Chemical Toxicology, 2013